Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For MDGL
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 74.72 9.39 5.38
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 2151.46 3.32 -0.15
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 107.37 42.53 20.51
Cash 65.00 52.95 32.09
Capex 65.96 -0.02 -0.05
Free Cash Flow -82.43 -7.48 -4.10
Revenue 0.00 0.00 0.00
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 0.00 0.00 0.00
Operating Margin 0.00 0.00 0.00
ROA 22.17 -0.14 -0.18
ROE 37.35 -0.17 -0.28
ROIC 30.08 -0.16 -0.22
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of MDGL is permitted for members.
5 Growth
The "Growth Entry" for the Focus of MDGL is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of MDGL is permitted for members.